These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 380367)

  • 1. Acute high-dose parenteral haloperidol treatment of psychosis.
    Lerner Y; Lwow E; Levitin A; Belmaker RH
    Am J Psychiatry; 1979 Aug; 136(8):1061-4. PubMed ID: 380367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flupenthixol versus haloperidol in acute psychosis.
    Parent M; Toussaint C
    Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acutely psychotic patients receiving high-dose haloperidol therapy.
    Remington G; Pollock B; Voineskos G; Reed K; Coulter K
    J Clin Psychopharmacol; 1993 Feb; 13(1):41-5. PubMed ID: 8486816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative efficacy of parenteral haloperidol and thiothixene for the emergency treatment of acutely excited and agitated patients.
    Stotsky BA
    Dis Nerv Syst; 1977 Dec; 38(12):967-73. PubMed ID: 338270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral prediction of response to haloperidol: a test dose strategy.
    Neborsky R; Janowsky D; Munson E; Hornbeck C; Depry D
    J Clin Psychiatry; 1982 Apr; 43(4):157-8. PubMed ID: 7068547
    [No Abstract]   [Full Text] [Related]  

  • 6. [Flupenthixol versus haloperidol in acute psychotic episodes].
    Parent M; Toussaint C
    Acta Psychiatr Belg; 1982; 82(6):617-31. PubMed ID: 7183131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential response to parenteral chlorpromazine and mesoridazine in psychotic patients.
    Brauzer B; Goldstein BJ
    J Clin Pharmacol J New Drugs; 1970; 10(2):126-31. PubMed ID: 4906541
    [No Abstract]   [Full Text] [Related]  

  • 8. Further evidence of a dose-response threshold for haloperidol in psychosis.
    Stone CK; Garve DL; Griffith J; Hirschowitz J; Bennett J
    Am J Psychiatry; 1995 Aug; 152(8):1210-2. PubMed ID: 7625474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
    Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
    J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J; Glitschka A; Müller K
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract]   [Full Text] [Related]  

  • 11. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.
    Schooler N; Rabinowitz J; Davidson M; Emsley R; Harvey PD; Kopala L; McGorry PD; Van Hove I; Eerdekens M; Swyzen W; De Smedt G;
    Am J Psychiatry; 2005 May; 162(5):947-53. PubMed ID: 15863797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study.
    Fruensgaard K; Korsgaard S; Jorgensen H; Jensen K
    Acta Psychiatr Scand; 1977 Oct; 56(4):256-64. PubMed ID: 335787
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
    O'Brien CP; DiGiacomo JN; Webb W
    Dis Nerv Syst; 1974 Feb; 35(2):75-8. PubMed ID: 17894044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral haloperidol in psychiatric emergencies. Double-blind comparison with chlorpromazine.
    Gerstenzang ML; Krulisky TV
    Dis Nerv Syst; 1977 Aug; 38(8):581-3. PubMed ID: 328243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of parenteral molindone and haloperidol in the acutely psychotic patient.
    Binder R; Glick I; Rice M
    J Clin Psychiatry; 1981 May; 42(5):203-6. PubMed ID: 7217025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
    Sachs GS; Grossman F; Ghaemi SN; Okamoto A; Bowden CL
    Am J Psychiatry; 2002 Jul; 159(7):1146-54. PubMed ID: 12091192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of a new butyrophenone in psychiatric service. Outline of a differential study].
    Digo R; Karavokyros D; Mlynarski JC
    Encephale; 1967; 56(1):75-91. PubMed ID: 5340034
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind- evaluation of bromperidol versus haloperidol treatment in chronic psychotic patients.
    Malfroid M; Hens L; Roosen P; Dom R
    Acta Psychiatr Belg; 1978; 78(1):147-54. PubMed ID: 347877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Citrome L; Meng X; Hochfeld M; Stahl SM
    Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.